AC Immune (ACIU) Assets Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.78% |
| Sep 30, 2025 | -23.90% |
| Jun 30, 2025 | -12.52% |
| Mar 31, 2025 | 22.50% |
| Dec 31, 2024 | 27.90% |
| Sep 30, 2024 | 74.15% |
| Jun 30, 2024 | 51.17% |
| Mar 31, 2024 | 4.80% |
| Dec 31, 2023 | 6.78% |
| Sep 30, 2023 | -23.94% |
| Jun 30, 2023 | -22.81% |
| Mar 31, 2023 | -28.29% |
| Dec 31, 2022 | -31.93% |
| Sep 30, 2022 | 95,982.08% |
| Jun 30, 2022 | 97,133.65% |
| Mar 31, 2022 | 101,044.55% |
| Dec 31, 2021 | 7.37% |
| Sep 30, 2021 | -99.92% |
| Jun 30, 2021 | -99.92% |
| Mar 31, 2021 | -99.92% |
| Dec 31, 2020 | -12.00% |
| Sep 30, 2020 | -12.90% |
| Jun 30, 2020 | -99.90% |
| Mar 31, 2020 | -5.15% |
| Dec 31, 2019 | 51.94% |
| Dec 31, 2018 | 47.26% |
| Dec 31, 2017 | -14.98% |
| Dec 31, 2016 | 95.25% |